Sensible Biotechnologies
- 07/04/2023
- Pre-Seed
- $4,200,000
At Sensible Biotechnologies, we are turning living cells into cost-efficient factories for manufacturing high-quality mRNA to unlock the full potential of mRNA therapeutics and vaccines.
- Industry Biotechnology Research
- Website https://www.sensible.bio/
- LinkedIn https://www.linkedin.com/company/sensible-biotechnologies/
Related People
Miroslav GasparekCo Founder
I am a bioengineer fascinated by the process of bringing life science and technological innovation all the way from the lab bench or computer screen to the market and end users.
I am interested in:
- Researching topics in applied synthetic biology, control theory and mathematical modelling in my doctoral studies at Oxford.
- Bringing a meaningfulbiotechnological innovation to the market via my work at stealth biotech startup.
- Supporting life science and technological innovation via Venture Capital & Private Equity investing, currently through Fellowship at Civilization Ventures.
- Wider societal implications of engineering biology through my Research Fellowship at Stanford University Existential Risk Initiative.
- Providing consulting and advisory services in the area of life sciences to companies and institutions, especially in Central and Eastern European region.
My research lies at the intersection of synthetic biology, control theory, and data-driven control methods (like Reinforcement Learning). Specifically, I am working on programming and controlling cells and designing complex engineered multicellular systems. I am interested in practical applications of synthetic biology, its wider societal impact and providing solutions to real-life problems and big societal challenges.
I like to ask a lot of questions, especially "Why?" and "Why does it matter?" Currently working on a couple of exciting stealth biotech and deep tech projects. If you are interested in my work or want to collaborate with me on interesting projects, feel free to contact me.